e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Clinical problems in acute and chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical significance of C reactive protein and MASTORA score in pulmonary embolism
E. Danila, J. Rackauskiene, V. Gedvilaite, M. Mataciunas, M. Abrutyte, O. Kusner (Vilnius, Klaipeda, Lithuania)
Source:
International Congress 2014 – Clinical problems in acute and chronic lung diseases
Session:
Clinical problems in acute and chronic lung diseases
Session type:
Thematic Poster Session
Number:
3659
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Danila, J. Rackauskiene, V. Gedvilaite, M. Mataciunas, M. Abrutyte, O. Kusner (Vilnius, Klaipeda, Lithuania). Clinical significance of C reactive protein and MASTORA score in pulmonary embolism. Eur Respir J 2014; 44: Suppl. 58, 3659
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Related content which might interest you:
Pulmonary embolism (PE) in patients with pulmonary sarcoidosis (PS)
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
From CTPA-proven pulmonary embolism to patients clinical characteristics
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013
Prognostic value of Mastora obstruction score in acute pulmonary embolism
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Analysis of importance of clinical and laboratory parameters for clinical course and outcome of septic or no septic pulmonary embolism
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013
Clinical phenotypes in pulmonary emboli identified by cluster analysis
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Clinical characteristics and prognostic factors of pulmonary embolism in different age groups
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013
Diagnostic value of PET-CT in pleural diseases
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Prognostic scores in pulmonary embolism: PESI, simplified PESI or PREP?
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013
Clinical assessment of pulmonary embolism rule-out criteria (PERC). Retrospective study (2006-2015)
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Prognostic value of TDI assessment of right ventricular function in patients with acute pulmonary embolism
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Prognostic value of MRI in pulmonary arterial hypertension: Early and late predictors
Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights
Year: 2015
Association between antiphospholipid antibody type and level and pulmonary manifestations in APS
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Comparison of 3 prediction scores for diagnosis of Pulmonary Embolism
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021
Clinical and prognostic scores in patients with cancer and pulmonary embolism
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Integration of the level of D-dimer (D-d) with Wells criteria to improve the prediction of pulmonary embolism (PE) before CT angiography of the lung (CTAL)
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Clinical usefulness of the oxygen uptake efficiency in pulmonary embolism
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014
Paradoxical response to bronchodilators: Radiologic correlates and clinical implications
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014
Analysis of Causes of Diagnostic Difficulties and Features of Clinical Course of Pulmonary Embolism
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Prognostic significance of right heart thrombi (RHT) in patients with acute symptomatic pulmonary embolism: Systematic review and meta-analysis
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Electrocardiographic abnormalities in patients with low or moderate risk pulmonary embolism: Prevalence and association with PO
2
/FiO
2
ratio
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept